Oracle Alpha Inc. CYTK Holdings History
Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$255,252.78
% of Total Estimate Gain
113.59%
Oracle Alpha Inc.'s Cytokinetics Inc Holding Summary
As of 2024-03-31, Oracle Alpha Inc. held - shares of Cytokinetics Inc(CYTK), totaling N/A. This investment constitutes 0% of their stock portfolio, and Oracle Alpha Inc. now holds 0% of the outstanding Cytokinetics Inc(CYTK) stock.
The initial trade took place in 2023Q4. In addition, there have been 1 sales at an average price of $77.34 for 6,206.00 shares. Based on historical transaction data and CYTK's current price of $34.66, Oracle Alpha Inc.'s estimated gain on his CYTK holdings is $255,252.78, reflecting a 113.59% gain to date.
Oracle Alpha Inc. CYTK ($34.66) Holding Chart
Oracle Alpha Inc. CYTK ($34.66) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers